EMEA-001039-PIP03-17
Key facts
Invented name |
|
Active substance |
Clostridium Botulinum neurotoxin type A (150 kD), free from complexing proteins
|
Therapeutic area |
Ophthalmology
|
Decision number |
P/0131/2018
|
PIP number |
EMEA-001039-PIP03-17
|
Pharmaceutical form(s) |
Powder for solution for injection
|
Condition(s) / indication(s) |
Treatment of hemifacial spasm
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
Merz Pharmaceuticals GmbH
Tel.: +49 6915031 |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|